Primary hyperoxaluria: Therapeutic options to surpass inequities in access

-

Room: MOA 6

Treatment of choice – siRNAs, The Cure?

Log in to add to favorites Add Personal Notes

Bernd Hoppe, Germany

Head
German Hyperoxaluria Center
Pediatric Nephrology Center Bonn

Presentations by Bernd Hoppe

Email: info@ipta2025.org
514-874-1717